Phapros Tbk. (PEHA)
PT Phapros Tbk
Rp 314
-4,00(-1,26%)
POSTPOST- Harga Pasar: Rp 314
- Volume Perdagangan: Rp 208.800
- Kapitalisasi Pasar: Rp 263.760.003.072
- Mata Uang: IDR
- Pasar: id_market
- Dividend Yield: -%
- Dividend Rate: Rp -
- Price to Book: 0,68
- Forward P/E: -
- Trailing P/E: -
- EPS Tahun Ini: Rp -248,99
- EPS Perkiraan: Rp -
- Bid: Rp 306,00
- Ask: Rp 314,00
- Bid Size: 0,00
- Ask Size: 0,00
- Volume Rata-rata 10 Hari: 227.180
- Volume Rata-rata 3 Bulan: 174.543
- Book Value: Rp 463,99
- Fifty Day Average: Rp 325,96
- Two Hundred Day Average: Rp 313,47
- 52 Week Range: 260.0 - 398.0
- 52 Week High: Rp 398,00
- 52 Week Low: Rp 260,00
- Regular Market Open: Rp 318,00
- Regular Market Previous Close: Rp 318,00
- Regular Market Day High: Rp 318,00
- Regular Market Day Low: Rp 304,00
- Earnings Call Start: -
- Earnings Call End: -
- Earnings Timestamp: -
Sektor
Healthcare
Industri
Drug Manufacturers - Specialty & Generic
Alamat Perusahaan
Menara Rajawali Lantai 17
Jl. Dr. Ide Anak Agung Gde Agung Kuningan
Jakarta Selatan
12950
Ringkasan Bisnis
PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, X-Gra, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.
Ebook ProfitWise - Metode FCDS-T mencari Saham MultiBagger(Terjual ke 2000+ Investor)
Metode FCDS-T: Strategi investasi dengan CAGR >35% yang membantu modal Rp100 juta berkembang menjadi Rp1,1 miliar dalam 8 tahun.
Cocok untuk investor yang ingin:
- Memiliki sinyal jual/beli jelas
- Aturan investasi objektif (tanpa emosi)
- Menghemat waktu (hanya 4x analisis/tahun)
- Mencapai tujuan finansial
Bonus: Template spreadsheet + Konsultasi gratis!